Hematologic Diseases: all 476 studies

Page 2 of 5. Open to participants first (109), then studies with results posted, then the rest; newest registration first within each.

• Collection and Distribution of Biospecimens for Novel Research UsesRecruitingNCT03848962
• Rapid Analysis of Infections by Spectrometry of Exhaled BreathRecruitingNCT03299608
• Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy VolunteersRecruitingNCT03207854
• Hematology Biobank: In Vitro Study of Blood DisordersRecruitingNCT02442011
• Registry of Philadelphia-Negative Myeloproliferative NeoplasmsRecruitingNCT02380378
• Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)RecruitingNCT01666080Not applicable
• Bone Marrow Grafting for Leukemia and LymphomaEnrolling by invitationNCT00186147
• Diamond Blackfan Anemia Registry (DBAR)RecruitingNCT00106015
• Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
• A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.CompletedNCT05228470Phase 2Results posted
• Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple MyelomaCompletedNCT05032820Phase 2Results posted
• A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Active, not recruitingNCT05023980Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive CrisesCompletedNCT04935879Phase 3Results posted
• A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive CrisesTerminatedNCT04927247Phase 3Results posted
• Study of Modified Atkins Diet in Kabuki SyndromeCompletedNCT04722315Early Phase 1Results posted
• Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Active, not recruitingNCT04666038Phase 3Results posted
• Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell TransplantationCompletedNCT04339101Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia ACompletedNCT04323098Phase 3Results posted
• Creative Arts Therapy (CAT) in the Center for Cancer and Blood DisordersCompletedNCT04208243Not applicableResults posted
• Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell TransplantationCompletedNCT04094844Not applicableResults posted
• Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia ATerminatedNCT04046848Phase 1/2Results posted
• A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia BActive, not recruitingNCT03861273Phase 3Results posted
• XIENCE 28 USA StudyCompletedNCT03815175Not applicableResults posted
• Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease PatientsActive, not recruitingNCT03814746Phase 3Results posted
• A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell DiseaseCompletedNCT03745287Phase 2/3Results posted
• Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII InhibitorsCompletedNCT03734588Phase 1/2Results posted
• TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated DonorsTerminatedNCT03615144Phase 2Results posted
• A Safety Study of SEA-BCMA in Patients With Multiple MyelomaTerminatedNCT03582033Phase 1Results posted
• Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.CompletedNCT03578367Phase 2Results posted
• Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5TerminatedNCT03520712Phase 1/2Results posted
• NASH Fitness Intervention in Thrombosis Trial (NASHFit)CompletedNCT03518294Not applicableResults posted
• Ibrutinib and PD-1 Blockade in High Risk Lymphocytic LeukemiaTerminatedNCT03514017Phase 2Results posted
• Thrombosomes® in Bleeding Thrombocytopenic PatientsCompletedNCT03394755Phase 1Results posted
• XIENCE 28 Global StudyCompletedNCT03355742Not applicableResults posted
• A Safety and Efficacy Study of NAC in Patients With TA-TMACompletedNCT03252925Phase 3Results posted
• Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological DisorderCompletedNCT03250845Results posted
• Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationTerminatedNCT03246906Phase 2Results posted
• Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced ThrombocytopeniaTerminatedNCT03195010Phase 2Results posted
• Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical TransplantationCompletedNCT03159702Phase 2Results posted
• Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic DisordersCompletedNCT03093844Not applicableResults posted
• Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology PatientsCompletedNCT03030248Phase 2Results posted
• A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological DisordersCompletedNCT02494258Phase 2Results posted
• Prospective Study of Patients With Thrombocytopenia Following HSCTCompletedNCT02487563Phase 3Results posted
• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of DosesCompletedNCT02467270Phase 2Results posted
• A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative MalignanciesCompletedNCT02158858Phase 1/2Results posted
• Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal DiseaseCompletedNCT02158052Not applicableResults posted
• Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic DiseasesTerminatedNCT02145039Not applicableResults posted
• Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeStatus unknownNCT02130882Phase 2/3Results posted
• Preemptive Ethanol Lock Therapy in Pediatric Bloodstream InfectionCompletedNCT02095951Phase 4Results posted
• Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT01924169Phase 2Results posted
• Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell LymphomaCompletedNCT01909934Phase 4Results posted
• Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell TransplantCompletedNCT01790568Phase 2Results posted
• A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MFCompletedNCT01787552Phase 1/2Results posted
• Dexamethasone Dyspnea StudyCompletedNCT01670097Phase 2Results posted
• Steroid Treatment for Hypereosinophilic SyndromeCompletedNCT01524536Phase 4Results posted
• Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MFCompletedNCT01423851Phase 1/2Results posted
• Cord Blood Transplantation for Patients With CancerTerminatedNCT01359254Phase 2Results posted
• Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)CompletedNCT01254318Results posted
• Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCTTerminatedNCT01220297Phase 2Results posted
• Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS DeviceCompletedNCT01210716Phase 3Results posted
• Ondansetron Versus Aprepitant Plus Ondansetron for EmesisCompletedNCT00954941Phase 2Results posted
• Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited DisordersCompletedNCT00919503Phase 2Results posted
• Busulfan and Fludarabine Followed by Post-transplant CyclophosphamideCompletedNCT00800839Phase 2Results posted
• BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)CompletedNCT00586521Phase 4Results posted
• Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological DiseasesCompletedNCT00582894Not applicableResults posted
• Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)TerminatedNCT00579111Phase 1/2Results posted
• Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand PatientsTerminatedNCT00555555Phase 4Results posted
• Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)TerminatedNCT00486720Phase 2Results posted
• Safety, Pharmacokinetics and Efficacy of an ATIII ConcentrateTerminatedNCT00319228Phase 2/3Results posted
• Myeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesCompletedNCT00309842Phase 2Results posted
• Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)CompletedNCT00231309Not applicableResults posted
• A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in ChildrenCompletedNCT00213239Phase 1/2Results posted
• A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSFTerminatedNCT00208949Phase 2Results posted
• T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersTerminatedNCT00176826Phase 2/3Results posted
• Stroke With Transfusions Changing to HydroxyureaTerminatedNCT00122980Phase 3Results posted
• Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell DiseaseTerminatedNCT00115336Phase 4Results posted
• Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular DiseaseCompletedNCT00071032Phase 3Results posted
• Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell AnemiaCompletedNCT00006400Phase 3Results posted
• Horse-assisted Interventions in an Oncological CentreCompletedNCT07831460Not applicable
• Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer ChemotherapyCompletedNCT07671547Phase 2/3
• Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell DiseaseTerminatedNCT07431398Phase 1
• Pacritinib With Aza for Upfront Myelodysplastic SyndromeWithdrawnNCT07387354Phase 1/2
• Autologous Transplantation of Human Cryopreserved Testis TissueActive, not recruitingNCT07364409Not applicable
• Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT PatientsCompletedNCT07200583
• Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE.CompletedNCT07099196Not applicable
• A Study Investigating Coagadex in the Treatment AFXD Associated With AL AmyloidosisWithdrawnNCT06963216Phase 3
• Precise Design of Cell Therapy for Relapsed and Refractory Hematological TumorsActive, not recruitingNCT06849921Not applicable
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy ParticipantsCompletedNCT06797375Phase 1
• A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in TaiwanActive, not recruitingNCT06684314
• Clinical Study of Combined Platelet TransfusionCompletedNCT06613425Phase 4
• Joint and Hematologic Disorders of Noonan Syndrome: French Descriptive Cross-sectional StudyCompletedNCT06550635
• The Combination of IVIG, Dexamethasone and a Megadose of PBSCs for Decreasing DSAsCompletedNCT06471478
• Radiological Characterization of Pulmonary Involvement in Patients With Hematological DiseasesCompletedNCT06350526
• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 1
• Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional StudyCompletedNCT06277479
• Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia AActive, not recruitingNCT06224907Phase 3
• Bleeding Events Before vs After Lowering Departmental Platelet Transfusion TriggerCompletedNCT06187831
• A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)CompletedNCT06144749Phase 2
• Multiple Myeloma Prognostic IndicesCompletedNCT06095752
• HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisActive, not recruitingNCT06001385Phase 2

← Hematologic Diseases overview